<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bekhterev</journal-id><journal-title-group><journal-title xml:lang="ru">Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева</journal-title><trans-title-group xml:lang="en"><trans-title>V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7053</issn><issn pub-type="epub">2713-055X</issn><publisher><publisher-name>V. M. BEKHTEREV  NATIONAL  RESEARCH  MEDICAL  CENTER  FOR  PSYCHIATRY  AND  NEUROLOGY                           OF    THE  RUSSIAN  FEDERATION   MINISTRY  OF  HEALTH</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31363/2313-7053-2024-1031</article-id><article-id custom-type="elpub" pub-id-type="custom">bekhterev-1081</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Ангедония в структуре постковидного синдрома у пациентов психиатрического стационара: вероятная роль ожирения, системного воспаления, сосудистой дисрегуляции и общетерапевтической коморбидности</article-title><trans-title-group xml:lang="en"><trans-title>Anhedonia in the structure of post-COVID syndrome in psychiatric inpatients: the probable role of obesity, systemic inflammation, vascular disregulation and general therapeutic comorbidity</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9481-7411</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лутова</surname><given-names>Н. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Lutova</surname><given-names>N. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лутова Наталия Борисовна - д.м.н., руководитель отделения интегративной фармако-психотерапии психических расстройств</p><p>Санкт-Петербург, 920191, ул. Бехтерева, д. 3.</p></bio><bio xml:lang="en"><p>Natalia B. Lutova</p><p>St. Petersburg</p></bio><email xlink:type="simple">lutova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5618-4206</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Незнанов</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Neznanov</surname><given-names>N.. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Незнанов Николай Григорьевич - д.м.н., профессор, заслуженный деятель науки РФ, директор; заведующий кафедрой психиатрии</p><p>Санкт-Петербург, 920191, ул. Бехтерева, д. 3.</p></bio><bio xml:lang="en"><p>Nikolai G. Neznanov</p><p>St. Petersburg</p></bio><email xlink:type="simple">spbinst@bekhterev.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-5872-7195</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шабельник</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shabelnik</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шабельник Антон Вадимович - аспирант отделения интегративной фармако-психотерапии психических расстройств</p><p>Санкт-Петербург, 920191, ул. Бехтерева, д. 3.</p></bio><bio xml:lang="en"><p>Anton V. Shabelnik</p><p>St. Petersburg</p></bio><email xlink:type="simple">dr.shabelnik.psy@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6317-5778</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Герасимчук</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Gerasimchuk</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Герасимчук Екатерина Сергеевна - младший научный сотрудник отделения интегративной фармако-психотерапии психических расстройств</p><p>Санкт-Петербург, 920191, ул. Бехтерева, д. 3</p></bio><bio xml:lang="en"><p>Ekaterina S. Gerasimchuk</p><p>St. Petersburg</p></bio><email xlink:type="simple">katherine.gerasimchuk@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2113-699X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бочарова</surname><given-names>М. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Bocharova</surname><given-names>M. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бочарова Мария Олеговна - к.м.н., младший научный сотрудник отделения интегративной фармако-психотерапии психических расстройств; исследователь</p><p>Санкт-Петербург, 920191, ул. Бехтерева, д. 3</p><p>Лондон</p></bio><bio xml:lang="en"><p>Maria O. Bocharova</p><p>St. Petersburg</p><p>London</p></bio><email xlink:type="simple">mariia.bocharova@kcl.ac.uk</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2502-6365</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сорокин</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Sorokin</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сорокин Михаил Юрьевич - к.м.н., ведущий научный сотрудник отделения интегративной фармако-психотерапии психических расстройств, учёный секретарь</p><p>Санкт-Петербург, 920191, ул. Бехтерева, д. 3</p></bio><bio xml:lang="en"><p>Mikhail Yu. Sorokin</p><p>St. Petersburg</p></bio><email xlink:type="simple">m.sorokin@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ “Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М.Бехтерева” Минздрава России; ФГБОУ ВО «ПСПбГМУ им. И.П. Павлова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology; I.P. Pavlov First St. Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева» Минздрава России; Королевский колледж Лондона</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology; King’s College London</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>16</day><month>12</month><year>2024</year></pub-date><volume>58</volume><issue>4-2</issue><fpage>100</fpage><lpage>110</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лутова Н.Б., Незнанов Н.Г., Шабельник А.В., Герасимчук Е.С., Бочарова М.О., Сорокин М.Ю., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Лутова Н.Б., Незнанов Н.Г., Шабельник А.В., Герасимчук Е.С., Бочарова М.О., Сорокин М.Ю.</copyright-holder><copyright-holder xml:lang="en">Lutova N.B., Neznanov N.G., Shabelnik A.V., Gerasimchuk E.S., Bocharova M.O., Sorokin M.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bekhterevreview.com/jour/article/view/1081">https://www.bekhterevreview.com/jour/article/view/1081</self-uri><abstract><p>COVID-19 стал причиной не только острых, но и отсроченных нейропсихиатрических нарушений. Высоковероятным проявлением последних может быть физическая ангедония, поскольку этот транснозологический психопатологический феномен связывают с нарушением метаболических и нейровоспалительных процессов. Цель. Выявить распространённость физической ангедонии в структуре клиники постковидного синдрома и оценить связь данного транснозологического психопатологического симптома с сопутствующей соматической отягощённостью, тяжестью перенесенной инфекции и временем, прошедшим после заболевания. Материал и методы. У 48 пациентов психиатрического стационара с тяжелыми психическими расстройствами оценили распространенность острых и отсроченных нейропсихиатрических симптомов в зависимости от анамнеза перенесённого COVID-19. Количественное и качественное измерение общетерапевтической коморбидности проводили по самоотчёту о числе одновременно присутствующих групп хронических заболеваний, а также объективно оценивали выраженность ожирения—по индексу массы тела, дизрегуляцию сосудистого тонуса - по вариабельности артериального давления, системное воспаление по - скорости оседания эритроцитов (СОЭ) и тромбоцитарно-лимфоцитарному соотношению (PLR). Физическую ангедонию выявляли с помощью русскоязычной версии пересмотренной шкалы физической ангедонии (RPAS). Результаты. Подтверждена ассоциация между тяжестью перенесенного COVID-19 и выраженностью ангедонии, как вероятного элемента постковидного синдрома. Суммарная общетерапевтическая отягощенность стала наиболее важным предиктором острых и отсроченных нейропсихиатрических нарушений на фоне COVID-19. В развитии поздних нарушений после коронавирусной инфекции была показана вероятная роль метаболического синдрома, системного воспаления и сосудистого тонуса. Заключение. Продемонстрирована важная роль общетерапевтической отягощённости, в том числе ожирения, со- судистой дизрегуляции и системного воспаления, в развитии ангедонии у больных психическими рас- стройствами, перенесшими COVID-19.</p></abstract><trans-abstract xml:lang="en"><p>COVID-19 caused not only acute but also delayed neuropsychiatric disorders. A highly probable manifestation of the latter may be physical anhedonia, since this transnosological psychopathological phenomenon is associated with a violation of metabolic and neuroinflammatory processes. The goal. To identify the prevalence of physical anhedonia in the clinic of post-COVID syndrome and to assess the association of this transnosological psychopathological symptom with concomitant somatic burden, the severity of the SARS-CoV-2 infection and the time elapsed since the disease. Materials and Methods. The prevalence of acute and delayed neuropsychiatric symptoms was assessed in 48 psychiatric inpatients with severe mental disorders depending on the history of COVID-19. Quantitative and qualitative assessment was carried out by self-reporting on the number of simultaneously present groups of chronic diseases, and the severity of obesity was objectively assessed - by body mass index, dysregulation of vascular tone-by blood pressure variability, systemic inflammation - by sed rate and platelet-lymphocyte ratio (PLR). Physical anhedonia was detected using the Russian-language version of the Revised physical anhedonia scale (RPAS). Results. The association between the severity of COVID-19 and the severity of anhedonia, as a probable component of post-COVID syndrome, was confirmed. The total general therapeutic burden was the most important predictor of acute and delayed neuropsychiatric symptoms against the background of COVID-19. The probable role of metabolic syndrome, systemic inflammation and vascular tone was shown in the development of late disorders after coronavirus infection. Conclusion. The role of general therapeutic burden (including obesity, vascular dysregulation and systemic inflammation) in the development of anhedonia in patients with mental disorders who have had COVID-19 has been demonstrated.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>long-COVID</kwd><kwd>индекс массы тела</kwd><kwd>дизрегуляция сосудистого тонуса</kwd><kwd>общая психопатология</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Post Acute COVID-19 Syndrome</kwd><kwd>Body Mass Index</kwd><kwd>Vasoplegia</kwd><kwd>Psychopathology</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено в рамках государственного задания ФГБУ «НМИЦ ПН им. В.М.Бехтерева» Минздрава России 2024-2026 гг. (XSOZ 2024 0012).</funding-statement><funding-statement xml:lang="en">The study was carried out within the framework of the state assignment of the Federal State Budgetary Educational Institution “V.M. Bekhterev’ National Research Medical Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation for 2024-2026. (XSOZ 2024 0012).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Крылов В.И. Ангедония при расстройствах аффективного и шизофренического спектра: психопатологические особенности, диагностическое и прогностическое значение. Психиатрия и психофармакотерапия. 2014;1:28-33.</mixed-citation><mixed-citation xml:lang="en">Krylov VI. Anhedonia affective and schizophrenia spectrum disorders: psychopathological features, diagnostic and prognostic value. Psihiatriya i psihofarmakoterapiya. 2014;1:28-33. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Лутова Н.Б., Хобейш М.А., Макаревич О.В., Бочарова М.О., Герасимчук Е.С., Сорокин М.Ю. Адаптация и валидация шкалы физической ангедонии (Revised Physical Anhedonia Scale): психометрические свойства русскоязычной ме- тодики. Психиатрия и психофармакотерапия. 2024;4:25-34.</mixed-citation><mixed-citation xml:lang="en">Lutova NB, Khobeysh MA, Makarevich OV, Bocharova MO, Gerasimchuk ES, Sorokin MYu. Adaptation and validation of the Physical Anhedonia Scale (Revised Physical Anhedonia Scale): psychometric properties of the Russian-speaking methodology. Psihiatriya i psihofarmakoterapiya. 2024;4:25-34. https://doi.org/10.62202/2075-1761-2024-26-4-25-34. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Мазо Г.Э., Кибитов А.О. Ангедония как базовый синдром и мишень для терапевтического воздействия при депрессивном расстройстве. Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева. 2019;(3):10-18.</mixed-citation><mixed-citation xml:lang="en">Mazo GE, Kibitov AO. Anhedonia as a basic syndrome and a target for treatment for depressive disorder. Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Bekhtereva. 2019;(3):10-18. https://doi.org/10.31363/2313-7053-2019-3-10-18. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Менделевич В.Д., Гатин Ф.Ф., Хамитов Р.Р. Чему эпидемия COVID-19 научила психиатров? Неврологический вестник. 2023;(4):5-13.</mixed-citation><mixed-citation xml:lang="en">Mendelevich VD, Gatin FF, Khamitov RR. What did the COVID-19 epidemic learn psychiatrists? Nevrologicheskij vestnik. 2023;(4):5-13. https://doi.org/10.17816/nb117637 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Менделевич Е.Г., Сайфеева А.А., Курбанов А.И. COVID-19-ассоциированный синдром ортостатической гипотензии: прямые и опосредованные механизмы развития. Неврологический вестник. 2021;(3):64-70.</mixed-citation><mixed-citation xml:lang="en">Mendelevich EG, Saifeeva AA, Kurbanov AI. COVID-19-associated orthostatic hypotension syndrome: direct and indirect mechanisms of development. Nevrologicheskij vestnik. 2021;(3):64-70. https://doi.org/10.17816/nb81629 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Менделевич В.Д. Понять ангедонию: от традиционного к феноменологическому анализу явления. Неврологический вестник. 2021;(3):44-50.</mixed-citation><mixed-citation xml:lang="en">Mendelevich VD. Understanding of anhedonia: from traditional to phenomenological analysis of the phenomena. Nevrologicheskij vestnik. 2021;(3):44-50. https://doi.org/10.17816/nb78185. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Незнанов Н.Г., Лиманкин О.В., Шабельник А.В., Азарова Л.А., Лутова Н.Б., Бочарова М.О., Сорокин М.Ю. Фактор психофармакотерапии в вариантах течения COVID-19 у пациентов психиатрического стационара. Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева. 2024;58(2):79-88.</mixed-citation><mixed-citation xml:lang="en">Neznanov NG, Limankin OV, Shabelnik AV, Azarova LA, Lutova NB, Bocharova MO, Sorokin MYu. Psychopharmacotherapy factor in the variants of COVID-19 course in psychiatric inpatients. Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Bekhtereva. 2024;58(2):79-88. https://doi.org/10.31363/2313-7053-2024-856. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Незнанов Н.Г., Сорокин М.Ю., Скрипов В.С., Есина К.М. Эпидемиология психических расстройств как маркер психиатрических факторов пандемии COVID-19. Российский психиатрический журнал. 2023;(1):4–13.</mixed-citation><mixed-citation xml:lang="en">Neznanov NG, Sorokin MYu, Skripov VS, Esina KM. Epidemiology of mental disorders as a marker of psychiatric factors of the COVID-19 pandemic. Rossiiskii psikhiatricheskii zhurnal. 2023;(1):4–13. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Сорокин М.Ю. Аффективные и когнитивные симптомы у перенесших COVID-19 пациен- тов: организационные выводы об оказании психиатрической помощи в периоды пандемии и по её окончании. Бюллетень медицинской на- уки. 2022;3(27):117-127.</mixed-citation><mixed-citation xml:lang="en">Sorokin MYu. Affective and cognitive symptoms in COVID-19 survivors: implications for organization of psychiatric services in the post pandemic and within pandemic period. Byulleten’ medicinskoĭ nauki. 2022;3(27):117-127. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Neurological Sequelae of COVID-19. J Integr Neurosci. 2022;21(3):77. https://doi.org/10.31083/j.jin2103077.</mixed-citation><mixed-citation xml:lang="en">Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Neurological Sequelae of COVID-19. J Integr Neurosci. 2022;21(3):77. https://doi.org/10.31083/j.jin2103077.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">AlJameel AH, AlSaleh LS, Bawazir NH, AlOmair AS, Almalki SA. How Mental Health Correlates with Subjective Oral Health Status: A Cross-Sectional Study among a Group of University Students. Niger J Clin Pract. 2023;26(11):1716-1722. https://doi.org/10.4103/njcp.njcp_330_23</mixed-citation><mixed-citation xml:lang="en">AlJameel AH, AlSaleh LS, Bawazir NH, AlOmair AS, Almalki SA. How Mental Health Correlates with Subjective Oral Health Status: A Cross-Sectional Study among a Group of University Students. Niger J Clin Pract. 2023;26(11):1716-1722. https://doi.org/10.4103/njcp.njcp_330_23</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">AlShakhs A, Almomen A, AlYaeesh I, et al. The Association of Smell and Taste Dysfunction with COVID19, And Their Functional Impacts. Indian J Otolaryngol Head Neck Surg. 2022;74(Suppl 2):2847-2852. https://doi.org/10.1007/s12070-020-02330-w</mixed-citation><mixed-citation xml:lang="en">AlShakhs A, Almomen A, AlYaeesh I, et al. The Association of Smell and Taste Dysfunction with COVID19, And Their Functional Impacts. Indian J Otolaryngol Head Neck Surg. 2022;74(Suppl 2):2847-2852. https://doi.org/10.1007/s12070-020-02330-w</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Amin V, Flores CA, Flores-Lagunes A. The impact of BMI on mental health: Further evidence from genetic markers. Econ Hum Biol. 2020;38:100895. https://doi.org/10.1016/j.ehb.2020.100895</mixed-citation><mixed-citation xml:lang="en">Amin V, Flores CA, Flores-Lagunes A. The impact of BMI on mental health: Further evidence from genetic markers. Econ Hum Biol. 2020;38:100895. https://doi.org/10.1016/j.ehb.2020.100895</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bisaccia G, Ricci F, Recce V, et al. Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?. J Cardiovasc Dev Dis. 2021;8(11):156. https://doi.org/10.3390/jcdd8110156</mixed-citation><mixed-citation xml:lang="en">Bisaccia G, Ricci F, Recce V, et al. Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?. J Cardiovasc Dev Dis. 2021;8(11):156. https://doi.org/10.3390/jcdd8110156</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Dani M, Dirksen A, Taraborrelli P, et al. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63-e67. https://doi.org/10.7861/clinmed.2020-0896</mixed-citation><mixed-citation xml:lang="en">Dani M, Dirksen A, Taraborrelli P, et al. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63-e67. https://doi.org/10.7861/clinmed.2020-0896</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recom- mendations. Nat Rev Microbiol. 2023;21(3):133- 146. https://doi.org/10.1038/s41579-022-00846-2</mixed-citation><mixed-citation xml:lang="en">Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recom- mendations. Nat Rev Microbiol. 2023;21(3):133- 146. https://doi.org/10.1038/s41579-022-00846-2</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">El Sayed S, Shokry D, Gomaa SM. Post-COVID-19 fatigue and anhedonia: A cross-sectional study and their correlation to post-recovery period. Neuropsychopharmacol Rep. 2021;41(1):50-55. https://doi.org/10.1002/npr2.12154</mixed-citation><mixed-citation xml:lang="en">El Sayed S, Shokry D, Gomaa SM. Post-COVID-19 fatigue and anhedonia: A cross-sectional study and their correlation to post-recovery period. Neuropsychopharmacol Rep. 2021;41(1):50-55. https://doi.org/10.1002/npr2.12154</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Fleischer E, Landaeta-Díaz L, González-Medina G, Horovitz O. Anxiety, anhedonia, and related food consumption in Israelis populations:An online cross-sectional study two years since the outbreak of COVID-19. Heliyon. 2023;9(6):e17211. https://doi.org/10.1016/j.heliyon.2023.e17211</mixed-citation><mixed-citation xml:lang="en">Fleischer E, Landaeta-Díaz L, González-Medina G, Horovitz O. Anxiety, anhedonia, and related food consumption in Israelis populations:An online cross-sectional study two years since the outbreak of COVID-19. Heliyon. 2023;9(6):e17211. https://doi.org/10.1016/j.heliyon.2023.e17211</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Gomzyakova N, Palchikova E, Tumova M, Kasyanov E, Sorokin M. Association of Anxiety and Depression with Objective and Subjective Cognitive Decline in Outpatient Healthcare Consumers with COVID-19: А Cross-Sectional Study. Consort Psychiatr. 2022;3(3):45-55. https://doi.org/10.17816/CP189</mixed-citation><mixed-citation xml:lang="en">Gomzyakova N, Palchikova E, Tumova M, Kasyanov E, Sorokin M. Association of Anxiety and Depression with Objective and Subjective Cognitive Decline in Outpatient Healthcare Consumers with COVID-19: А Cross-Sectional Study. Consort Psychiatr. 2022;3(3):45-55. https://doi.org/10.17816/CP189</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Gouraud C, Bottemanne H, Lahlou-Laforêt K, et al. Association Between Psychological Distress, Cognitive Complaints, and Neuropsychological Status After a Severe COVID-19 Episode: A Cross-Sectional Study. Front Psychiatry. 2021;12:725861. https://doi.org/10.3389/fpsyt.2021.725861</mixed-citation><mixed-citation xml:lang="en">Gouraud C, Bottemanne H, Lahlou-Laforêt K, et al. Association Between Psychological Distress, Cognitive Complaints, and Neuropsychological Status After a Severe COVID-19 Episode: A Cross-Sectional Study. Front Psychiatry. 2021;12:725861. https://doi.org/10.3389/fpsyt.2021.725861</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Husain M, Roiser JP. Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nat Rev Neurosci. 2018;19(8):470-484. https://doi.org/10.1038/s41583-018-0029-9</mixed-citation><mixed-citation xml:lang="en">Husain M, Roiser JP. Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nat Rev Neurosci. 2018;19(8):470-484. https://doi.org/10.1038/s41583-018-0029-9</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its Management. Int J Biol Sci. 2022;18(12):4768-4780. https://doi.org/10.7150/ijbs.75056.</mixed-citation><mixed-citation xml:lang="en">Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its Management. Int J Biol Sci. 2022;18(12):4768-4780. https://doi.org/10.7150/ijbs.75056.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ly M, Yu GZ, Mian A, et al. Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer’s disease, and Depression. Am J Geriatr Psychiatry. 2023;31(10):853-866. https://doi.org/10.1016/j.jagp.2023.06.001.</mixed-citation><mixed-citation xml:lang="en">Ly M, Yu GZ, Mian A, et al. Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer’s disease, and Depression. Am J Geriatr Psychiatry. 2023;31(10):853-866. https://doi.org/10.1016/j.jagp.2023.06.001.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110(21):3484-3496. https://doi.org/10.1016/j.neuron.2022.10.006.</mixed-citation><mixed-citation xml:lang="en">Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110(21):3484-3496. https://doi.org/10.1016/j.neuron.2022.10.006.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Moustafa IM, Ahbouch A, Kader RP, Shousha TM, Alrahoomi A. A Comparison of Sensorimotor Integration and Motor Fitness Components between Collegiate Athletes with and without Long COVID: A Cross-Sectional Study with Pair-Matched Controls. J Clin Med. 2024;13(9):2469. https://doi.org/10.3390/jcm13092469.</mixed-citation><mixed-citation xml:lang="en">Moustafa IM, Ahbouch A, Kader RP, Shousha TM, Alrahoomi A. A Comparison of Sensorimotor Integration and Motor Fitness Components between Collegiate Athletes with and without Long COVID: A Cross-Sectional Study with Pair-Matched Controls. J Clin Med. 2024;13(9):2469. https://doi.org/10.3390/jcm13092469.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Seon JY, Kim S, Hong M, Lim MK, Oh IH. Risk of COVID-19 diagnosis and death in patients with mental illness: a cohort study. Epidemiol Psychiatr Sci. 2021;30:e68. https://doi.org/10.1017/S2045796021000597.</mixed-citation><mixed-citation xml:lang="en">Seon JY, Kim S, Hong M, Lim MK, Oh IH. Risk of COVID-19 diagnosis and death in patients with mental illness: a cohort study. Epidemiol Psychiatr Sci. 2021;30:e68. https://doi.org/10.1017/S2045796021000597.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Sorokin M, Markin K, Kibitov A, Palchikova E, Zubova E. The Mind-Body Problem in the Context of Neuropsychiatric Symptoms in Patients with Coronavirus Disease 2019. Alpha Psychiatry. 2023;24(6):257-260. https://doi.org/10.5152/alphapsychia-try.2023.231178.</mixed-citation><mixed-citation xml:lang="en">Sorokin M, Markin K, Kibitov A, Palchikova E, Zubova E. The Mind-Body Problem in the Context of Neuropsychiatric Symptoms in Patients with Coronavirus Disease 2019. Alpha Psychiatry. 2023;24(6):257-260. https://doi.org/10.5152/alphapsychia-try.2023.231178.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic [who.int]. who; 2024. Available: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic.</mixed-citation><mixed-citation xml:lang="en">Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic [who.int]. who; 2024. Available: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Stefanou MI, Palaiodimou L, Bakola E, et al. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022;13:20406223221076890. https://doi.org/10.1177/20406223221076890.</mixed-citation><mixed-citation xml:lang="en">Stefanou MI, Palaiodimou L, Bakola E, et al. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022;13:20406223221076890. https://doi.org/10.1177/20406223221076890.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Walker VM, Patalay P, Cuitun Coronado JI, et al. COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People. JAMA Psychiatry. 2024:e242339. https://doi.org/10.1001/jamapsychiatry.2024.2339.</mixed-citation><mixed-citation xml:lang="en">Walker VM, Patalay P, Cuitun Coronado JI, et al. COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People. JAMA Psychiatry. 2024:e242339. https://doi.org/10.1001/jamapsychiatry.2024.2339.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
